Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Infosys, LivePerson to help in customer experience transformation Indian IT services company Infosys has joined forces with US-based conversational AI provider LivePerson to bring in customer… byPallavi MadhirajuApril 1, 2021
